NNNNAnbio Biotechnology Class A Ordinary Shares

NAS · US · Healthcare · Medical Instruments & Supplies · anbiobiotechnology.com

6.810USDMkt Cap: 298.90M $P/E: 45.403d ago

Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, and internationally. The company offers lateral flow immunoassay, fluorescence immun…

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc.

$135.72BUSDP/E 43.4

EssilorLuxottica Societe anonyme

$81.53BUSDP/E 30.5

BDX

Becton, Dickinson and Company

$52.30BUSDP/E 33.2

MDLN

Medline Inc. Class A Common Stock

West Pharmaceutical Services, Inc.

$24.85BUSDP/E 45.2

DIM

Sartorius Stedim Biotech

$20.46BUSDP/E 64.5

SRT3

Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

$14.73BUSDP/E 69.1

SOLV

Solventum Corporation Common Stock

$15.25BUSDP/E 10.9

COO

The Cooper Companies, Inc.

$14.87BUSDP/E 64.6

BAX

Baxter International Inc.

$13.62BUSD

ALGN

Align Technology, Inc.

Key Statistics

Company

Market Cap298.90M $

Enterprise Value309.82M $

Revenue (TTM)8.65M $

Gross Profit7.54M $

Net Income (TTM)6.40M $

Revenue/Share0.1980 USD

Last Price6.810 USD

Fiscal Year EndDec 2025

MR QuarterDec 2025

Employees27

CountryUS

SectorHealthcare

IndustryMedical Instruments & Supplies

ISIN—

Valuation

P/E (Trailing)45.40

P/E (Forward)—

PEG—

EV/EBITDA—

EV/Revenue35.83

P/S37.21

P/B10.67

EPS (TTM)0.14

EPS (Forward)—

52W Range

6.61027% of range7.350

52W High7.350 USD

52W Low6.610 USD

Profitability

Gross Margin87.24%

Oper. Margin59.09%

EBITDA Margin0.00%

Profit Margin74.06%

ROE21.24%

ROA21.17%

Growth

Revenue Growth73.90%

Earnings Growth—

Cash Flow & Leverage

Operating CF-6.74M $

CapEx (TTM)—

FCF Margin-111.09%

FCF Yield-3.21%

Net Debt-11.90M $

Net Debt/EBITDA—

Balance Sheet

Debt/Equity—

Current Ratio344.31

Quick Ratio177.13

Book Value/Sh0.6870 USD

Cash/Share0.2710 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.43.89M

Float39.69M

Insiders4.78%

Institutions4.95%

Short Interest

Short Ratio1.1d

Short % Float0.11%

Short % Out.0.11%

Shares Short47.52K

Short (prev mo.)89.30K

Technical

SMA 5011.80 (-42.3%)

SMA 20023.21 (-70.7%)

Beta—

S&P 52W Chg21.00%

Avg Vol (30d)78.59K

Avg Vol (10d)176.89K

Technical Indicators

RSI (14)27.2

MACD-1.2273

MACD Signal-1.1057

MACD Hist.-0.1216

BB Upper12.12 USD

BB Middle9.602 USD

BB Lower7.085 USD

BB Width52.43%

ATR (14)1.704 USD

Vol Ratio (20d)0.69x